In malignant, sporadic non-NF1-associated tumors such as pheochromocytoma, lung adenocarcinoma, breast cancer, ovarian cancer, glioblastoma and many others, somatic pathogenic variants of NF1 are also important targets. Here, NF1 is linked to lung adenocarcinoma.